Direct evidence of c-MYC’s involvement in human cancer came from the discovery and identification of the c-MYC gene at 8q24 and its translocation onto the immunoglobulin heavy chain locus in human Burkitt lymphoma [3,4,5]. This evidence concerns the gene MYC and Burkitt lymphoma.